J. Keul

3.1k total citations
142 papers, 2.1k citations indexed

About

J. Keul is a scholar working on Complementary and alternative medicine, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, J. Keul has authored 142 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Complementary and alternative medicine, 29 papers in Cardiology and Cardiovascular Medicine and 29 papers in Cell Biology. Recurrent topics in J. Keul's work include Cardiovascular and exercise physiology (32 papers), Muscle metabolism and nutrition (29 papers) and Sports Performance and Training (24 papers). J. Keul is often cited by papers focused on Cardiovascular and exercise physiology (32 papers), Muscle metabolism and nutrition (29 papers) and Sports Performance and Training (24 papers). J. Keul collaborates with scholars based in Germany, Switzerland and Austria. J. Keul's co-authors include M. Lehmann, E. Doll, Aloys Berg, H. Reindell, H.-H. Dickhuth, M. Huonker, Martin Halle, Ernst Jakob, Jürgen Finke and Roland Mertelsmann and has published in prestigious journals such as Journal of Applied Physiology, European Heart Journal and Medicine & Science in Sports & Exercise.

In The Last Decade

J. Keul

137 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Keul Germany 26 669 619 593 431 361 142 2.1k
J. Keul Germany 23 868 1.3× 639 1.0× 758 1.3× 623 1.4× 401 1.1× 121 2.4k
C. Préfaut France 30 905 1.4× 456 0.7× 405 0.7× 271 0.6× 270 0.7× 151 3.0k
Robert J. Moffatt United States 29 604 0.9× 445 0.7× 749 1.3× 385 0.9× 195 0.5× 73 2.2k
M. A. Rogers United States 21 735 1.1× 451 0.7× 594 1.0× 693 1.6× 342 0.9× 39 2.3k
Kevin O’Reilly United States 12 354 0.5× 161 0.3× 517 0.9× 444 1.0× 306 0.8× 28 2.0k
O Mustala Finland 10 526 0.8× 455 0.7× 259 0.4× 83 0.2× 151 0.4× 29 1.6k
C. N. Meredith United States 21 578 0.9× 187 0.3× 965 1.6× 959 2.2× 734 2.0× 26 2.9k
Herbert Gustavo Simões Brazil 30 1.3k 1.9× 890 1.4× 848 1.4× 397 0.9× 419 1.2× 211 2.9k
Michael A. Welsch United States 23 594 0.9× 799 1.3× 317 0.5× 112 0.3× 103 0.3× 85 2.0k
Karen M. Birch United Kingdom 28 370 0.6× 783 1.3× 804 1.4× 165 0.4× 207 0.6× 71 2.5k

Countries citing papers authored by J. Keul

Since Specialization
Citations

This map shows the geographic impact of J. Keul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Keul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Keul more than expected).

Fields of papers citing papers by J. Keul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Keul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Keul. The network helps show where J. Keul may publish in the future.

Co-authorship network of co-authors of J. Keul

This figure shows the co-authorship network connecting the top 25 collaborators of J. Keul. A scholar is included among the top collaborators of J. Keul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Keul. J. Keul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keul, J., et al.. (2025). Advantages and Disadvantages of Drug Combination Treatment: Riluzole, Metformin and Dexamethasone Effect on Glioblastoma Cell. Anticancer Research. 45(5). 1813–1823. 1 indexed citations
2.
Schumacher, Y O, Peter P. Mueller, & J. Keul. (2001). Development of peak performance in track cycling.. PubMed. 41(2). 139–46. 30 indexed citations
3.
Jakob, Ernst, et al.. (2000). Patients with Fibromyalgia Benefit from Aerobic Endurance Exercise. Clinical Rheumatology. 19(4). 253–253. 19 indexed citations
4.
Schmid, Andreas, et al.. (1998). Verletzungsrisiko von behinderten Leistungssportlern im Skilanglauf in der Trainings- und Wettkampfphase. Sportverletzung · Sportschaden. 12(1). 26–30. 7 indexed citations
5.
König, Daniel, Christof Weinstock, J. Keul, Hinnak Northoff, & Aloys Berg. (1998). Zinc, iron, and magnesium status in athletes--influence on the regulation of exercise-induced stress and immune function.. PubMed. 4. 2–21. 36 indexed citations
6.
Sorichter, Stephan, M. Huonker, Johannes Mair, et al.. (1997). MUSCLE PROTEIN RELEASE IN YOUNG MALE AND FEMALE TRIATHLETES DURING INTENSIVE ENDURANCE TRAINING 365. Medicine & Science in Sports & Exercise. 29(Supplement). 63–63. 1 indexed citations
7.
Lehmann, M., Ernst Jakob, U. Gastmann, et al.. (1995). Unaccustomed high mileage compared to intensity training-related neuromuscular excitability in distance runners. European Journal of Applied Physiology. 70(5). 457–461. 13 indexed citations
8.
Rokitzki, L, et al.. (1993). Pantothensäurekonzentrationen im Blut von Leistungssportlern in Ruhe und unter aerober Ausdauerbelastung. Zeitschrift für Ernährungswissenschaft. 32(4). 282–288. 3 indexed citations
9.
Frey, Ingrid, et al.. (1992). Distribution of lipoprotein species (LpA-I, LpA-I:A-II) in serum and HDL subfractions of untrained and trained normolipemic men. Clinica Chimica Acta. 211(3). 167–173. 4 indexed citations
10.
Lehmann, M., et al.. (1988). Ski-Flying: Related Catecholamine Excretion Compared with Cross-Country Skiing*. International Journal of Sports Medicine. 9(6). 438–442. 6 indexed citations
11.
Bodemann, H. H., et al.. (1985). Ferritin in erythrocytes and plasma of patients with iron overload. Annals of Hematology. 51(1). 25–31. 4 indexed citations
12.
Lehmann, M. & J. Keul. (1983). Korrelationen zwischen h�modynamischen Gr��en und Plasmakatecholaminen bei Normo- und Hypertonikern in Ruhe und w�hrend K�rperarbeit. Journal of Molecular Medicine. 61(8). 403–408. 3 indexed citations
13.
Keul, J.. (1982). The athlete's heart-haemodynamic and structure. International Journal of Sports Medicine. 3. 33–43. 16 indexed citations
14.
Lehmann, M., J. Keul, & U. Korsten-Reck. (1981). Einflu\ einer stufenweisen Laufbandergometrie bei Kindern und Erwachsenen auf die Plasmacatecholamine, die aerobe und anaerobe KapazitÄt. European Journal of Applied Physiology. 47(3). 301–311. 41 indexed citations
15.
Keul, J., Greg Huber, & M Lehmann. (1979). [Heart rate and metabolic values in long-lasting automobile trips under beta-receptor blockade (Bunitrolol)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30(28). 1080–5. 1 indexed citations
16.
Kindermann, Wilfried, J. Keul, & M. Lehmann. (1979). [Prolonged exercise in the adolescent--metabolic and cardiovascular changes. Metabolic and cardiovascular changes in 11 to 14-year-old boys during a 10 km race].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 97(14). 659–65. 3 indexed citations
17.
Keul, J., et al.. (1976). [Effect of a new beta-receptor blockader (Bunitrolol) on the circulation and metabolism during extreme stress conditions].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(9). 437–43. 4 indexed citations
18.
Reindell, H., et al.. (1967). [Volume and output of healthy and diseased hearts].. PubMed. 472. 88–112. 1 indexed citations
19.
Keul, J., et al.. (1966). [On the metabolism of the heart in highly trained athletes. I. Substrate supply of the trained heart at rest, during and after physical work].. PubMed. 55(2). 190–215. 7 indexed citations
20.
Roskamm, H., H. Reindell, & J. Keul. (1962). [The physiological bases of various training methods].. PubMed. 13. 109–23 concl. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026